Neuralink to trial brain implant in Canada, aiming to help paralysed patients control devices through thought.
Elon Musk's Neuralink announced it has received approval to conduct its first clinical trial in Canada for a brain implant designed to enable paralysed individuals to operate digital devices through thought.
The study, conducted at Toronto's University Health Network hospital, will evaluate the implant's safety and functionality for individuals with quadriplegia. Health Canada has not commented on the approval.
Neuralink has already implanted the device in two U.S. patients, with one using it successfully for tasks like playing video games and 3D design.
Founded in 2016, the company is developing brain chip interfaces to aid disabled individuals in movement, communication, and vision restoration. In September, it received FDA "breakthrough device" status for its vision-restoring implant.
Read next
23:20
U.S. Defense Secretary Pete Hegseth told Indo-Pacific allies Saturday they won’t be left alone against growing military and economic pressure from China—but they must also boost their own defense efforts.
22:43
Iran said on Saturday that it has officially received a new nuclear deal proposal from U.S. President Donald Trump, delivered by Oman during a diplomatic visit to Tehran.
20:40
Russia-USA
Hamas said on Saturday it had officially responded to a ceasefire plan put forward by U.S. envoy Steve Witkoff, who represents President Donald Trump in Middle East diplomacy. The group said its reply includes a key demand: a complete end to the war.
18:35
Saudi Arabia and Qatar will provide joint financial support for Syrian state employees, Saudi Foreign Minister Prince Faisal bin Farhan announced during a visit to Damascus, as regional efforts to support Syria’s reconstruction gain momentum.
17:34
world news
China has strongly criticised French President Emmanuel Macron's remarks linking Ukraine and Taiwan, calling them a “double standard” and insisting the two issues are not comparable.
What is your opinion on this topic?
Leave the first comment